This peptide-pathway genetic assessment (different from pharmacogenomic testing) identifies how your biology influences GLP-1 response, GIP sensitivity, and appetite-regulation mechanisms
Effects on lipid metabolism In vitro studies indicate that ESC, at concentrations ranging from 12.5 to 100 M, decreases lipid accumulation in 3T3-L1 adipocytes in a dose-dependent manner
NLRP3 activation in hepatocytes can also lead to caspase 1-mediated pyroptosis, or inflammasome-mediated lytic cell death, amplifying the release of DAMPs beyond just apoptotis-associated DAMP release (176)
B12 testing is recommended in patients with fatty liver disease who have: Symptoms suggestive of deficiency (anaemia, neuropathy, cognitive changes) Long-term metformin use (MHRA 2022 guidance advises monitoring) Long-term proton pump inhibitor use Vegetarian or vegan diets Conditions affecting absorption (pernicious anaemia, coeliac disease, gastric surgery) Advanced liver disease (NASH, fibrosis, or cirrhosis) Monitoring frequency should be individualised based on disease severity and risk factors
